DataMeds AI, Inc. (MEDS) Operating Margin
- Operating margin · 12 months: Value -875.75%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -875.75% | Operating income / revenue. Period ending 2026-06-30. $-70.26M ÷ $8.02M × 100 ≈ -875.75% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -70.26M USD | Operating Income (Loss) |
| Revenue | 8.02M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | (m) | |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-70.26M | $8.02M | (m) | (m) | (m) | -875.75% |
| 2026-03-31 | $-68.42M | $14.03M | (m) | (m) | (m) | -487.50% |
| 2025-12-31 | $-93.75M | $23.34M | (m) | (m) | (m) | -401.70% |
| 2025-09-30 | $-72.14M | $34.08M | (m) | (m) | (m) | -211.71% |
| 2025-06-30 | $-42.34M | $36.74M | (m) | (m) | (m) | -115.25% |
| 2025-03-31 | $-37.41M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $-6.15M | $18.13M | (m) | (m) | (m) | -33.90% |
| 2024-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $-2.88M | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |